After a series of delays, Johnson & Johnson MedTech is almost ready to launch the first-in-human clinical trial of its Ottava soft-tissue robotic surgery system.
On 7 November, the company announced plans to request an investigational device exemption (IDE) from the US Food & Drug Administration to initiate a clinical trial of Ottava in the...